OptimizeRx Corporation Common Stock (OPRX) is a publicly traded Healthcare sector company. As of October 27, 2026, OPRX trades at $9.23 with a market cap of $172.35M and a P/E ratio of 31.27. OPRX moved +0.00% today. Year to date, OPRX is -26.97%; over the trailing twelve months it is -58.16%. Its 52-week range spans $3.99 to $22.25. Analyst consensus is strong buy with an average price target of $13.00. Rallies surfaces OPRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks OPRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $9.23 |
| Market Cap | $172.35M |
| P/E Ratio | 31.27 |
| EPS | $0.28 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.25 |
| 52-Week Low | $3.99 |
| Volume | 18.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $109.43M |
| Net Income | $5.13M |
| Gross Margin | 67.25% |
5 analysts cover OPRX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.00.